T&R Biofab티앤알바이오팹
246710 · KOSDAQ · ₩246710 · 티앤알바이오팹
₩1,820▼ ₩57 (3.04%)End-of-day · Oct 30, 2026 · End-of-day prices.
T&R Biofab246710· Biotech & PharmaInitiation
T&R Biofab: Revenue Jumped in 2025 but Losses and Leverage Remain Heavy
T&R Biofab, a KOSDAQ-listed biotech and pharma company, had a market value of ₩98.9B at a close of ₩2,075 on 2026-10-19. Revenue rose sharply in 2025, but the company is still loss-making, with high leverage and a negative return on equity.
Oct 20, 20260 views
Read the research reportReport history
This is not financial advice. The report does not recommend buying or selling anything.
Also known as: T&R Biofab / 티앤알바이오팹 / 246710 / KRX:246710
Source: KRX statistical information